WATSON 779
Pill imprint WATSON 779 has been identified as Oxybutynin chloride 5 mg.
Oxybutynin is used in the treatment of overactive bladder; urinary incontinence; dysuria; hyperhidrosis; prostatitis and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy.
Oxybutynin 5 mg is not subject to the Controlled Substances Act.
See also related documents.
Oxybutynin chloride Images
- Imprint:
-
WATSON 779
- Strength:
- 5 mg
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Urinary antispasmodics
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00591-0779
Advertisement
More Oxybutynin Chloride resources
- Oxybutynin
- Oxybutynin (Wolters Kluwer)
- Oxybutynin Extended-Release Tablets (Wolters Kluwer)
- Oxybutynin Gel (Wolters Kluwer)
- Oxybutynin Syrup (Wolters Kluwer)
- Oxybutynin System (Wolters Kluwer)
- oxybutynin (Cerner Multum)
- oxybutynin topical (Cerner Multum)
- oxybutynin transdermal (Cerner Multum)
- oxybutynin (Micromedex) - Includes Dosage Information
- oxybutynin Transdermal (Micromedex) - Includes Dosage Information
- Oxybutynin Chloride (AHFS DI)
- Oxybutynin (FDA)
- Oxybutynin Chloride (FDA)
- Oxybutynin Oral Solution (FDA)
- Oxybutynin Syrup (FDA)
- Oxybutynin Chloride (Wolters Kluwer)
Search Again
